Motif Bio PLC | Key People and Executives
Graham George Lumsden
Chief Executive Officer & Executive Director
Jonathan E. Gold
Chief Financial Officer & Executive Director
Zaki Hosny
Non-Executive Director
Richard Cecil Eversfield Morgan
Non-Executive Chairman
Craig Thomas Albanese
Independent Non-Executive Director
Mary Lake Polan
Independent Non-Executive Director
Bruce Andrew Williams
Independent Non-Executive Director
Maria Charlotta Ginman-Jones
Independent Non-Executive Director
Graham George Lumsden
Chief Executive Officer & Executive Director
Jonathan E. Gold
Chief Financial Officer & Executive Director
David B. Huang
Chief Medical Officer
Rajesh B. Shukla
Vice President-Clinical Operations
Stephanie Noviello
Vice President-Clinical Development
Zaki Hosny
Non-Executive Director
Richard Cecil Eversfield Morgan
Non-Executive Chairman
Craig Thomas Albanese
Independent Non-Executive Director
Mary Lake Polan
Independent Non-Executive Director
Bruce Andrew Williams
Independent Non-Executive Director
Maria Charlotta Ginman-Jones
Independent Non-Executive Director
| Address |
5 Independence Way
Princeton New Jersey 08540
United States
|
|
Employees
|
- |
| Website |
https://www.motifbio.com/ |
| Updated |
07/08/2019 |
| Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi). The company was founded on November 20, 2014 and is headquartered in New York, NY. |
